Reduced Geminin levels promote cellular senescence

Mechanisms of Ageing and Development

Volumn 134, Issue 1-2, 2013, Pages 10-23

  Iliou, Maria S ^a   Kotantaki, Panorea ^a   Karamitros, Dimitris ^a   Spella, Magda ^a   Taraviras, Stavros ^a   Lygerou, Zoi ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Cdt1; DNA damage; Geminin; Oxidative stress; Senescence

Indexed keywords

GEMININ; REPLICATION LICENSING FACTOR CDT1;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE S PHASE; CELL SUBPOPULATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FIBROBLAST; GENE DOSAGE; HETEROZYGOSITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RNA INTERFERENCE; SENESCENCE; SIGNAL TRANSDUCTION; STRESS;

ANIMALS; CELL AGING; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; EMBRYO, MAMMALIAN; FIBROBLASTS; G1 PHASE; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; MICE; S PHASE; SMN COMPLEX PROTEINS;

EID: 84872866030     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2012.10.001     Document Type: Article

References (63)

1. Abbas T., Dutta A. CRL4Cdt2: master coordinator of cell cycle progression and genome stability. Cell Cycle 2011, 10:241-249.
2. Agherbi H., Gaussmann-Wenger A., Verthuy C., Chasson L., Serrano M., Djabali M. Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence. PLoS ONE 2009, 4:e5622.
3. Ballabeni A., Melixetian M., Zamponi R., Masiero L., Marinoni F., Helin K. Human Geminin promotes pre-RC formation and DNA replication by stabilizing CDT1 in mitosis. EMBO Journal 2004, 23:3122-3132.
4. Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., Vassiliou L.V., Kolettas E., Niforou K., Zoumpourlis V.C., Takaoka M., Nakagawa H., Tort F., Fugger K., Johansson F., Sehested M., Andersen C.L., Dyrskjot L., Orntoft T., Lukas J., Kittas C., Helleday T., Halazonetis T.D., Bartek J., Gorgoulis V.G. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006, 444:633-637.
5. Blow J.J. Preventing re-replication of DNA in a single cell cycle: evidence for a replication licensing factor. Journal of Cell Biology 1993, 122:993-1002.
6. Bracken A.P., Kleine-Kohlbrecher D., Dietrich N., Pasini D., Gargiulo G., Beekman C., Theilgaard-Monch K., Minucci S., Porse B.T., Marine J.C., Hansen K.H., Helin K. The polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes and Development 2007, 21:525-530.
7. Brookes S., Rowe J., Gutierrez Del Arroyo A., Bond J., Peters G. Contribution of p16(INK4a) to replicative senescence of human fibroblasts. Experimental Cell Research 2004, 298:549-559.
8. Chen J.H., Stoeber K., Kingsbury S., Ozanne S.E., Williams G.H., Hales C.N. Loss of proliferative capacity and induction of senescence in oxidatively stressed human fibroblasts. Journal of Biological Chemistry 2004, 279:49439-49446.
9. Collado M., Serrano M. Senescence in tumours: evidence from mice and humans. Nature Reviews Cancer 2010, 10:51-57.
10. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003, 426:194-198.
11. Di Micco R., Fumagalli M., Cicalese A., Piccinin S., Gasparini P., Luise C., Schurra C., Garre M., Nuciforo P.G., Bensimon A., Maestro R., Pelicci P.G., d'Adda di Fagagna F. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006, 444:638-642.
12. Dietrich N., Bracken A.P., Trinh E., Schjerling C.K., Koseki H., Rappsilber J., Helin K., Hansen K.H. Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus. EMBO Journal 2007, 26:1637-1648.
13. Dimitrova D.S., Berezney R. The spatio-temporal organization of DNA replication sites is identical in primary, immortalized and transformed mammalian cells. Journal of Cell Science 2002, 115:4037-4051.
14. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:9363-9367.
15. Gonzalez M.A., Tachibana K.E., Chin S.F., Callagy G., Madine M.A., Vowler S.L., Pinder S.E., Laskey R.A., Coleman N. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. Journal of Pathology 2004, 204:121-130.
16. Gonzalez S., Klatt P., Delgado S., Conde E., Lopez-Rios F., Sanchez-Cespedes M., Mendez J., Antequera F., Serrano M. Oncogenic activity of Cdc6 through repression of the INK4/ARF locus. Nature 2006, 440:702-706.
17. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
18. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Experimental Cell Research 1961, 25:585-621.
19. Helin K. Regulation of cell proliferation by the E2F transcription factors. Current Opinion in Genetics and Development 1998, 8:28-35.
20. Karamitros D., Kotantaki P., Lygerou Z., Veiga-Fernandes H., Pachnis V., Kioussis D., Taraviras S. Differential Geminin requirement for proliferation of thymocytes and mature T cells. Journal of Immunology 2010, 184:2432-2441.
21. Kingsbury S.R., Loddo M., Fanshawe T., Obermann E.C., Prevost A.T., Stoeber K., Williams G.H. Repression of DNA replication licensing in quiescence is independent of Geminin and may define the cell cycle state of progenitor cells. Experimental Cell Research 2005, 309:56-67.
22. Kuilman T., Michaloglou C., Mooi W.J., Peeper D.S. The essence of senescence. Genes and Development 2010, 24:2463-2479.
23. Lin J.J., Dutta A. ATR pathway is the primary pathway for activating G2/M checkpoint induction after re-replication. Journal of Biological Chemistry 2007, 282:30357-30362.
24. Liu E., Lee A.Y., Chiba T., Olson E., Sun P., Wu X. The ATR-mediated S phase checkpoint prevents rereplication in mammalian cells when licensing control is disrupted. Journal of Cell Biology 2007, 179:643-657.
25. Luo L., Yang X., Takihara Y., Knoetgen H., Kessel M. The cell-cycle regulator Geminin inhibits Hox function through direct and polycomb-mediated interactions. Nature 2004, 427:749-753.
26. Maiorano D., Moreau J., Mechali M. XCDT1 is required for the assembly of pre-replicative complexes in Xenopus laevis. Nature 2000, 404:622-625.
27. Mallette F.A., Ferbeyre G. The DNA damage signaling pathway connects oncogenic stress to cellular senescence. Cell Cycle 2007, 6:1831-1836.
28. Mallette F.A., Gaumont-Leclerc M.F., Ferbeyre G. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes and Development 2007, 21:43-48.
29. Markey M., Siddiqui H., Knudsen E.S. Geminin is targeted for repression by the retinoblastoma tumor suppressor pathway through intragenic E2F sites. Journal of Biological Chemistry 2004, 279:29255-29262.
30. McGarry T.J., Kirschner M.W. Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 1998, 93:1043-1053.
31. Melixetian M., Ballabeni A., Masiero L., Gasparini P., Zamponi R., Bartek J., Lukas J., Helin K. Loss of Geminin induces rereplication in the presence of functional p53. Journal of Cell Biology 2004, 165:473-482.
32. Mihaylov I.S., Kondo T., Jones L., Ryzhikov S., Tanaka J., Zheng J., Higa L.A., Minamino N., Cooley L., Zhang H. Control of DNA replication and chromosome ploidy by Geminin and cyclin A. Molecular and Cellular Biology 2002, 22:1868-1880.
33. Musahl C., Holthoff H.P., Lesch R., Knippers R. Stability of the replicative Mcm3 protein in proliferating and differentiating human cells. Experimental Cell Research 1998, 241:260-264.
34. Narita M., Nunez S., Heard E., Narita M., Lin A.W., Hearn S.A., Spector D.L., Hannon G.J., Lowe S.W. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003, 113:703-716.
35. Nishitani H., Lygerou Z., Nishimoto T., Nurse P. The Cdt1 protein is required to license DNA for replication in fission yeast. Nature 2000, 404:625-628.
36. Nishitani H., Sugimoto N., Roukos V., Nakanishi Y., Saijo M., Obuse C., Tsurimoto T., Nakayama K.I., Nakayama K., Fujita M., Lygerou Z., Nishimoto T. Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis. EMBO Journal 2006, 25:1126-1136.
37. Nishitani H., Taraviras S., Lygerou Z., Nishimoto T. The human licensing factor for DNA replication Cdt1 accumulates in G1 and is destabilized after initiation of S-phase. Journal of Biological Chemistry 2001, 276:44905-44911.
38. Petropoulou C., Kotantaki P., Karamitros D., Taraviras S. Cdt1 and Geminin in cancer: markers or triggers of malignant transformation?. Frontiers in Bioscience 2008, 13:4485-4494.
39. Polager S., Kalma Y., Berkovich E., Ginsberg D. E2Fs up-regulate expression of genes involved in DNA replication, DNA repair and mitosis. Oncogene 2002, 21:437-446.
40. Ren B., Cam H., Takahashi Y., Volkert T., Terragni J., Young R.A., Dynlacht B.D. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes and Development 2002, 16:245-256.
41. Rialland M., Sola F., Santocanale C. Essential role of human CDT1 in DNA replication and chromatin licensing. Journal of Cell Science 2002, 115:1435-1440.
42. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. Journal of Biological Chemistry 1998, 273:5858-5868.
43. Rojas-Gil A.P., Ziros P.G., Diaz L., Kletsas D., Basdra E.K., Alexandrides T.K., Zadik Z., Frank S.J., Papathanassopoulou V., Beratis N.G., Papavassiliou A.G., Spiliotis B.E. Growth hormone/JAK-STAT axis signal-transduction defect. A novel treatable cause of growth failure. FEBS J 2006, 273:3454-3466.
44. Sasaki T., Li A., Gillespie P.J., Blow J.J., Gilbert D.M. Evidence for a mammalian late-G1 phase inhibitor of replication licensing distinct from Geminin or Cdk activity. Nucleus 2011, 2:455-464.
45. Seo S., Herr A., Lim J.W., Richardson G.A., Richardson H., Kroll K.L. Geminin regulates neuronal differentiation by antagonizing Brg1 activity. Genes and Development 2005, 19:1723-1734.
46. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997, 88:593-602.
47. Spella M., Britz O., Kotantaki P., Lygerou Z., Nishitani H., Ramsay R.G., Flordellis C., Guillemot F., Mantamadiotis T., Taraviras S. Licensing regulators Geminin and Cdt1 identify progenitor cells of the mouse CNS in a specific phase of the cell cycle. Neuroscience 2007, 147:373-387.
48. Stoeber K., Mills A.D., Kubota Y., Krude T., Romanowski P., Marheineke K., Laskey R.A., Williams G.H. Cdc6 protein causes premature entry into S phase in a mammalian cell-free system. EMBO Journal 1998, 17:7219-7229.
49. Stoeber K., Tlsty T.D., Happerfield L., Thomas G.A., Romanov S., Bobrow L., Williams E.D., Williams G.H. DNA replication licensing and human cell proliferation. Journal of Cell Science 2001, 114:2027-2041.
50. Sun W., Hola M., Pedley K., Tada S., Blow J.J., Todorov I.T., Kearsey S.E., Brooks R.F. The replication capacity of intact mammalian nuclei in Xenopus egg extracts declines with quiescence, but the residual DNA synthesis is independent of Xenopus MCM proteins. Journal of Cell Science 2000, 113(Pt 4):683-695.
51. Tada S. Cdt1 and Geminin: role during cell cycle progression and DNA damage in higher eukaryotes. Frontiers in Bioscience 2007, 12:1629-1641.
52. Tada S., Li A., Maiorano D., Mechali M., Blow J.J. Repression of origin assembly in metaphase depends on inhibition of RLF-B/Cdt1 by Geminin. Nature Cell Biology 2001, 3:107-113.
53. Truong L.N., Wu X. Prevention of DNA re-replication in eukaryotic cells. Molecular and Cellular Biology 2011, 3:13-22.
54. Vaziri C., Saxena S., Jeon Y., Lee C., Murata K., Machida Y., Wagle N., Hwang D.S., Dutta A. A p53-dependent checkpoint pathway prevents rereplication. Molecular Cell 2003, 11:997-1008.
55. Wagner M., Hampel B., Bernhard D., Hala M., Zwerschke W., Jansen-Durr P. Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis. Experimental Gerontology 2001, 36:1327-1347.
56. Wohlschlegel J.A., Dwyer B.T., Dhar S.K., Cvetic C., Walter J.C., Dutta A. Inhibition of eukaryotic DNA replication by Geminin binding to Cdt1. Science 2000, 290:2309-2312.
57. Wohlschlegel J.A., Kutok J.L., Weng A.P., Dutta A. Expression of Geminin as a marker of cell proliferation in normal tissues and malignancies. American Journal of Pathology 2002, 161:267-273.
58. Xouri G., Lygerou Z., Nishitani H., Pachnis V., Nurse P., Taraviras S. Cdt1 and Geminin are down-regulated upon cell cycle exit and are over-expressed in cancer-derived cell lines. European Journal of Biochemistry 2004, 271:3368-3378.
59. Xouri G., Squire A., Dimaki M., Geverts B., Verveer P.J., Taraviras S., Nishitani H., Houtsmuller A.B., Bastiaens P.I., Lygerou Z. Cdt1 associates dynamically with chromatin throughout G1 and recruits Geminin onto chromatin. EMBO Journal 2007, 26:1303-1314.
60. Yoshida K. Geminin organizes the molecular platform to balance cellular proliferation and differentiation. Frontiers in Bioscience 2007, 12:2984-2992.
61. Zhu W., Chen Y., Dutta A. Rereplication by depletion of Geminin is seen regardless of p53 status and activates a G2/M checkpoint. Molecular and Cellular Biology 2004, 24:7140-7150.
62. Zhu W., Depamphilis M.L. Selective killing of cancer cells by suppression of Geminin activity. Cancer Research 2009, 69:4870-4877.
63. Zhu W., Dutta A. An ATR- and BRCA1-mediated Fanconi anemia pathway is required for activating the G2/M checkpoint and DNA damage repair upon rereplication. Molecular and Cellular Biology 2006, 26:4601-4611.